Arbutus Biopharma Stock Price (NASDAQ:ABUS)

Add to My Stocks
$6.75 $0.4 (6.3%) ABUS stock closing price Jun 18, 2018 (Closing)
Prev Close* : $6.35
Market Cap:
$350.32M
Day Low: $6.21
52 Week Low: $3.20
Open: $6.3
Volume: -
Day High: $6.8
52 Week High: $8.25
Dividend:
0.00

Latest Stock Market News

Latest Articles

Arbutus Biopharma News - From Partners

ABUS Stockcharts

View ABUS PE ratio, PS ratio stocks charts and compare with peers.
ABUS Chart
Note: Compare Arbutus Biopharma stock price history with the index and industry peers.

Arbutus Biopharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
26.01
PB ratio (
price to book ratio
)
1.62

Arbutus Biopharma Returns

ROE
(return on equity)
-44%

Arbutus Biopharma Financial Ratios

Asset Turnover
0.02
Receivables Turnover
4.84
Debt to Equity
0
Dividend Yield
0%

ABUS Industry Peers

Company Price Change (%)
Starpharma (SPHRY)8.960.16 (1.75%)
Erytech Pharma (ERYP)18.070.18 (0.99%)
Marina Biotech (MRNA)0.720 (0%)
Benitec Biopharma (BNTC)2.190.21 (8.75%)
Spectrum Pharma (SPPI)19.890.06 (0.3%)
Bristol-myers Squibb (BMY)53.651.15 (2.1%)
Bioasis Technologies (BIOAF)0.530.01 (1.85%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Verastem (VSTM)8.582.05 (31.39%)
China Biologic Products (CBPO)99.3917.35 (21.15%)
Arbutus Biopharma (ABUS)6.750.4 (6.3%)
Uniquire (QURE)37.621.82 (5.08%)
SESEN BIO INC (SESN)2.210.1 (4.74%)
Merrimack Pharma (MACK)9.50.42 (4.63%)
Vericel Corp (VCEL)12.350.5 (4.22%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jun 18, 2018
CompanyPriceChange (%)
Catalyst Biosciences (CBIO)9.1116.14 (63.92%)
ZIOPHARM Oncology (ZIOP)3.510.79 (18.37%)
Cytokinetics (CYTK)8.251.65 (16.67%)
ELOXX PHARMACT (ELOX)20.852.42 (10.4%)
Idera Pharma (IDRA)1.560.14 (8.24%)
Geron (GERN)4.020.26 (6.07%)
Kindred Biosciences (KIN)10.50.6 (5.41%)
Top losers from Medical-Biomed-Genetics industry
* As of Jun 18, 2018

Arbutus Biopharma Corp Stock News - Partner Headlines

Arbutus Biopharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues10.7M1.49M24.87M14.95M15.46M
Net Income-84.41M-384.16M-61.12M-38.83M-14.06M
Total Operating Expense121.61M493.11M127.18M47.39M26.99M
View Arbutus Biopharma income statement
balance sheet20172016201520142013
Total Assets237.16M275.91M712.29M118.17M71.71M
Total Liabilities54.68M72.91M164.61M30.14M12.52M
Shareholders Equity182.47M203M547.67M88.03M59.19M
View Arbutus Biopharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities3.14M-0.46M-14.63M16.51M2.29M
Net Cash from (used by) Operating Activities-48.64M-57.88M-54.78M-12.42M-6.73M
Increase (Decrease) in Prop Plant And Equipment-7.26M-3.97M-2.28M-0.97M-0.72M
View Arbutus Biopharma cash flow statement

Arbutus Biopharma Stock Message Board

Arbutus Biopharma stock gained 6.3%, and the last close price as of Jun 18, 2018 is $6.75 for ABUS stock. Stock price or share price can be used to find the total market value of a company. Arbutus Biopharma market cap stands at $350.32M as of Jun 18, 2018. Arbutus Biopharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Arbutus Biopharma stock price and Arbutus Biopharma share price mean the same thing. 377,424 shares were traded with a closing stock price of $6.75 as of Jun 18, 2018, as can be seen from Arbutus Biopharma stock quote. One can view Arbutus Biopharma stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Arbutus Biopharma does not pay dividends. Arbutus Biopharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.